BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Almeida V, Levin R, Peres FF, Suiama MA, Vendramini AM, Santos CM, Silva ND, Zuardi AW, Hallak JEC, Crippa JA, Abílio VC. Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit. Neuropharmacology 2019;155:44-53. [DOI: 10.1016/j.neuropharm.2019.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 de Almeida V, Seabra G, Reis-de-Oliveira G, Zuccoli GS, Rumin P, Fioramonte M, Smith BJ, Zuardi AW, Hallak JEC, Campos AC, Crippa JA, Martins-de-Souza D. Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes. Eur Arch Psychiatry Clin Neurosci 2022. [PMID: 35622101 DOI: 10.1007/s00406-022-01425-5] [Reference Citation Analysis]
2 Navarro D, Gasparyan A, Navarrete F, Torregrosa AB, Rubio G, Marín-Mayor M, Acosta GB, Garcia-Gutiérrez MS, Manzanares J. Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders. Int J Mol Sci 2022;23:4764. [PMID: 35563156 DOI: 10.3390/ijms23094764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Scienza-martin K, Lotz FN, Zanona QK, Santana-kragelund F, Crestani AP, Boos FZ, Calcagnotto ME, Quillfeldt JA. Memory consolidation depends on endogenous hippocampal levels of anandamide: CB1 and M4, but possibly not TRPV1 receptors mediate AM404 effects. Neuroscience 2022. [DOI: 10.1016/j.neuroscience.2022.04.009] [Reference Citation Analysis]
4 Cheng W, Zheng J. Distribution and Assembly of TRP Ion Channels. Adv Exp Med Biol 2021;1349:111-38. [PMID: 35138613 DOI: 10.1007/978-981-16-4254-8_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Paredes-Ruiz KJ, Chavira-Ramos K, Orozco-Morales M, Karasu C, Tinkov AA, Aschner M, Santamaría A, Colín-González AL. On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence. Neurotox Res 2021. [PMID: 34741755 DOI: 10.1007/s12640-021-00424-z] [Reference Citation Analysis]
6 Di Marzo V. The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
. Dialogues Clin Neurosci 2020;22:259-69. [PMID: 33162769 DOI: 10.31887/DCNS.2020.22.3/vdimarzo] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
7 Escelsior A, Sterlini B, Murri MB, Serafini G, Aguglia A, da Silva BP, Corradi A, Valente P, Amore M. Red-hot chili receptors: A systematic review of TRPV1 antagonism in animal models of psychiatric disorders and addiction. Behavioural Brain Research 2020;393:112734. [DOI: 10.1016/j.bbr.2020.112734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhang L, Liu C, Yuan M. Eriodictyol produces antidepressant-like effects and ameliorates cognitive impairments induced by chronic stress. NeuroReport 2020;31:1111-20. [DOI: 10.1097/wnr.0000000000001525] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Radaic A, Martins-de-souza D. The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment. Nanomedicine: Nanotechnology, Biology and Medicine 2020;28:102222. [DOI: 10.1016/j.nano.2020.102222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Navarrete F, García-Gutiérrez MS, Jurado-Barba R, Rubio G, Gasparyan A, Austrich-Olivares A, Manzanares J. Endocannabinoid System Components as Potential Biomarkers in Psychiatry. Front Psychiatry 2020;11:315. [PMID: 32395111 DOI: 10.3389/fpsyt.2020.00315] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 23.5] [Reference Citation Analysis]